Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on. 

The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021. 

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

“Many studies look at the risk of a single condition in relation to dementia, but health is more complex than that,” one researcher said.

The study's authors examined data from more than 1.4 million patients, noting that pulmonary embolism response teams appear to be playing a significant role. 

The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque. 

Some decisions after a cyberattack are reactive and made on the fly, but imaging operations can take a number of steps ahead of time to plan for unplanned downtime and limit the impact of a temporary outage.